You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Renal Cell Carcinoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer Trial in Shanghai (SHR-1210, Famitinib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Shanghai, Shanghai, China
    Huadong Hospital Affiliated to Fudan University
Jun 30, 2022

Renal Cell Carcinoma Trial (HS-10516)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Sep 24, 2023

Renal Cell Carcinoma, First-line Treatment, Non Clear Cell Renal Cell Carcinoma Trial in Chengdu (AK104, Axitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • +3 more
  • Chengdu, Sichuan, China
    West China Hospital
Apr 10, 2023

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

Recruiting
  • Advanced Colorectal Carcinoma
  • +15 more
  • Fermented Wheat Germ Extract
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jul 26, 2023

Renal Cell Carcinoma, Ovarian Tumor Trial in Japan, United States (DS-6000a)

Recruiting
  • Renal Cell Carcinoma
  • Ovarian Tumor
  • Lake Mary, Florida
  • +6 more
Aug 2, 2022

Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

Recruiting
  • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
  • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
  • Shanghai, Shanghai, China
    Shanghai Renji Hospital
Sep 12, 2023

Collect Pre-existing Data on Administration of Cabozantinib in

Recruiting
  • Advanced Renal Cell Carcinoma
    • Amiens, France
    • +27 more
    Dec 26, 2022

    Advanced Renal Cell Carcinoma Trial in Rochester (Carevive software)

    Recruiting
    • Advanced Renal Cell Carcinoma
    • Carevive software
    • Rochester, New York
      University of Rochester - Wilmot Cancer Institute
    Jan 4, 2022

    Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 19, 2023

    Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

    Not yet recruiting
    • Advanced Clear Cell Renal Carcinoma (Ccrcc)
    • Papillary Renal Cell Carcinoma (Prcc)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Seattle (Aldesleukin,

    Recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +3 more
    • Aldesleukin
    • Pembrolizumab
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 5, 2022

    Advanced Renal Cell Carcinoma Trial in United States (CMN-001, Nivolumab+Ipilimumab, Lenvatinib+Everolimus)

    Recruiting
    • Advanced Renal Cell Carcinoma
    • CMN-001
    • +2 more
    • Tampa, Florida
    • +6 more
    Feb 10, 2022

    Metastatic Melanoma, Metastatic Breast Cancer, Advanced Renal Cell Carcinoma Trial in Worldwide (single arm)

    Withdrawn
    • Metastatic Melanoma
    • +5 more
    • single arm
    • (no location specified)
    Dec 20, 2022

    Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)

    Terminated
    Has Results
    • Renal Cell Carcinoma
    • Nivolumab
    • Ipilimumab
    • Saint Louis, Missouri
    • +11 more
    Dec 15, 2022

    Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

    Recruiting
    • Renal Cell Carcinoma
    • Beijing, China
    • +1 more
    Mar 28, 2023

    Advanced Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Duarte (Clostridium

    Active, not recruiting
    • Advanced Renal Cell Carcinoma
    • +5 more
    • Clostridium butyricum CBM 588 Probiotic Strain
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Oct 12, 2022

    Advanced Renal Cell Carcinoma Trial in Spain (Pazopanib + interferon alpha 2A)

    Completed
    • Advanced Renal Cell Carcinoma
    • Pazopanib + interferon alpha 2A
    • Hospitalet de Llobregat, Barcelona, Spain
    • +12 more
    Mar 9, 2022

    Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)

    Recruiting
    • Non-Clear Cell Renal Cell Carcinoma
    • Duarte, California
      Exelixis Clinical Site #1
    Jan 13, 2023

    Fumarate Hydratase Deficient Renal Cell Carcinoma Trial (Tislelizumab, Lenvatinib)

    Not yet recruiting
    • Fumarate Hydratase Deficient Renal Cell Carcinoma
    • (no location specified)
    May 18, 2023

    Renal Cell Carcinoma Metastatic Trial in France (KidneyPRO, standard follow-up)

    Recruiting
    • Renal Cell Carcinoma Metastatic
    • KidneyPRO
    • standard follow-up
    • Angers, France
    • +12 more
    May 2, 2022

    Carcinoma, Renal Cell Trial in United States (Belzutifan)

    Recruiting
    • Carcinoma, Renal Cell
    • Boston, Massachusetts
    • +3 more
    Jan 27, 2023

    Solid Tumor, Adult, Advanced Solid Tumor, Advanced Renal Cell Carcinoma Trial in Australia (89Zr-TLX250, 177Lu-TLX250 and

    Recruiting
    • Solid Tumor, Adult
    • +2 more
    • 89Zr-TLX250
    • 177Lu-TLX250 and Peposertib
    • North Ryde, New South Wales, Australia
    • +4 more
    May 22, 2023

    Renal Cell Carcinoma Trial in United States (Nivolumab, Axitinib)

    Recruiting
    • Renal Cell Carcinoma
    • Baltimore, Maryland
    • +3 more
    Nov 16, 2021

    Cabozantinib Post First-line Immuno-oncology Checkpoint

    Completed
    • Advanced Renal Cell Carcinoma (aRCC)
      • Glasgow, United Kingdom
      • +8 more
      Jun 30, 2022

      Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma Trial (BGB-A445, Tislelizumab)

      Not yet recruiting
      • Urothelial Carcinoma
      • +2 more
      • (no location specified)
      Dec 15, 2022